Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
Sponsor: Glaukos Corporation
Listed as NCT01841450, this NA trial focuses on Primary Open Angle Glaucoma and remains ongoing. Sponsored by Glaukos Corporation, it has been updated 12 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Nov 2021 — Nov 2023 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Phase: PHASE4 → NA
-
Aug 2018 — Dec 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jan 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Glaukos Corporation
For direct contact, visit the study record on ClinicalTrials.gov .